phosphodiesterase 7B (PDE7B) (Middle Region) Peptide
-
- Target See all PDE7B products
- PDE7B (phosphodiesterase 7B (PDE7B))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDE7B antibody (Catalog #: ARP55364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDE7B (phosphodiesterase 7B (PDE7B))
- Synonyms
- PDE7B Peptide, ba472e5.1 Peptide, bA472E5.1 Peptide, phosphodiesterase 7B Peptide, PDE7B Peptide, pde7b Peptide, Pde7b Peptide
- Background
-
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates a
Alias Symbols: MGC88256, bA472E5.1
Protein Size: 450 - Molecular Weight
- 52 kDa
- Gene ID
- 27115
- NCBI Accession
- NM_018945, NP_061818
- UniProt
- Q9NP56
-